AUTH/3482/3/21 - Complainant v GlaxoSmithKline

Alleged promotion of Nucala (mepolizumab) on LinkedIn

  • Received
    04 March 2021
  • Case number
    AUTH/3482/3/21
  • Applicable Code year
    2019
  • Completed
    01 December 2021
  • Additional sanctions
  • Appeal
    No appeal

Case Summary

No summary as outwith the scope of the Code

Completed cases